References

References

•Abinader A, Hanley AJ, Lozada CJ. Letter: Catastrophic Antiphospholipid Syndrome associated with anti-beta-2-glycoprotein I IgA. Rheumatology 1999; 38(1):84.

•Amital H, Levy Y, Davidson C. Catastrophic Antiphospholipid Syndrome: Remission following leg amputation in 2 cases. Semin Arthritis Rheum 2001; 31: 127-132.

•Andre M, Delevaux I, Amoura Z. Ovarian Vein Thrombosis in the Antiphospholipid Syndrome. Arthritis and Rheumatology 2004; 50(1): 183-186.

•Asherson R A, Cervera R. ‘Primary’ ‘Secondary’ and Other Variants of the Antiphospholipid Syndrome. Lupus 1994; 3:293-298.

•Asherson R A, Cervera R, Piette JC. Catastrophic Antiphospholipid Syndrome: Clues to the pathogenesis from a series of 80 patients. Medicine 2001; 80: 355-357.

•Asherson, R A, Espinosa G, Yinh J. Relapsing Catastrophic Antiphospholipid Syndrome: Report of Three Cases. Semin Arthritis Rheum 2008; 37: 366-372.

•Berkun Y, Padeh S. Antiphospholipid Syndrome and Recurrent Thrombosis in Children. Arthritis and Rheumatology 2006; 55(6): 850-855.

•Bortolati M, Marson P, Fabris F. Recovery from catastrophic antiphospholipid syndrome by a plasma exchange procedure: report of four cases and review of the literature. Autoimmunity Reviews 2009 Feb;8(4):297-301.

•Bucciarelli S, Cervera R, Espinosa G. Mortality of the catastrophic antiphospholipid syndrome: causes of death and prognostic factors. Autoimmunity Reviews 2006; 6: 72-75.

•Cerveny KC, Sawitzke AD. Relapsing catastrophic antiphospholipid antibody syndrome: a mimic for thrombotic thrombocytopenic purpura. Lupus 1999;8(6):477-81.

•Cervera R, Piette JC, Font J. Antiphospholipid Syndrome. Arthritis and Rheumatology 2002; 46(4): 1019-1027.

•Christiansen SC. Thrombophilia, Clinical Factors and Recurrent Venous Thrombotic Events. JAMA 2005; 293(19): 2352-2361.

•Cisternas M, Gutierrez M. Catastrophic Antiphospholipid Syndrome associated with crescentic glomerulonephritis: a clinicopathologic case. Clinical and Experimental Rheumatology 2000; 18:252-254.

•Cushman M, Tsai A, White R. Deep Vein Thrombosis and Pulmonary Embolism in two cohorts: The longitudinal investigation of thromboembolism etiology. American Journal of Medicine 2004 Jul 1;117(1):19-25.

•Ekran D, Asherson RA. Long term outcome of catastrophic antiphospholipid syndrome survivors. Ann Rheum Dis 2003; 62: 530-532.

•Elster S, Horn H, Tuchman L. Cardiac Hypertrophy and Insufficiency of Unknown Etiology. American Journal of Medicine 1955 Jun;18(6):900-22.

•Espinosa G, Bucciarelli S, Cervera R. Thrombotic microangiophathic haemolytic anaemia and antiphospholipid antibodies. Ann Rheum Dis 2004; 63: 730-736.

•Gomez-Puerta J. Catastrophic antiphospholipid syndrome in pregnancy and puerperium: maternal and fetal characteristics of 15 cases. Ann Rheum Dis 2007; 66:740-746.

•Jurgensen J. Catastrophic Antiphospholipid Syndrome masquerading as ischemic colitis. Rheumatol Int 2003; 23: 204-206.

•Key, N S. Intensity of warfarin anticoagulation in APS. J Thromb Haemost 2005; 3: 2368-9.

•Kitchens C. Thrombotic Storm: When thrombosis begets thrombosis. The American Journal of Medicine 2004; 1998 Apr;104(4):381-5.

•Kitchens CS1, Erkan D, Brandão LR, Hahn S, James AH, Kulkarni R, Pericak-Vance M, Vance J, Ortel TL.
Thrombotic storm revisited: preliminary diagnostic criteria suggested by the thrombotic storm study group.

•Langer F. Exacerbation of antiphospholipid antibody syndrome after treatment of localized cancer: a report of two cases. Ann Hematol 2002; 81:727-31.

•Levin J S. The Antiphospholipid Syndrome.New England Journal of Medicine 2002; 346(10): 752-763.

•Magee C C. Case 2-2008: A 38-year-old woman with postpartum visual loss, shortness of breath, and renal failure. New England Journal of Medicine 2008. 358: 275-289.

•Munoz-Rodriquez F J. Clinical study and follow up of 100 patients with the antiphospholipid syndrome. Seminars in Arthritis and Rheumatism 1999; 29(3): 182-190.

•Ortel T. Thrombosis and the Antiphospholipid Syndrome. Hematology 2005; 462-468.

•Park J M. Catastrophic Antiphospholipid Syndrome in a 7-year-old girl. Clinical Rheumatology 2006. 2007 Jun;26(6):1011-3.

•Piette J C, Cacoub P. Antiphospholipid Syndrome in the elderly: Caution. Journal of the American Heart Association 1998; 97: 2195-2196.

•Pugliatti P, Bella G D. Non compaction cardiomyopathy and antiphospholipid syndrome: a catastrophic thromboembolic association. International Journal of Cardiology 2008. 128: 126-128.

•Ortel TL1, Kitchens CS, Erkan D, Brandão LR, Hahn S, James AH, Kulkarni R, Manco-Johnson MJ, Pericak-Vance M, Vance J.
Clinical causes and treatment of the thrombotic storm.

•Quenby S, Farquharson R G. Recurrent miscarriage and long-term thrombosis risk: A case-control study. Human Reproduction 2005; 20(6): 1729-1732.

•Rosove M H. Antiphospolipid Thrombosis: Clinical course after the first thrombotic event in 70 patients. Annals of Internal Medicine 1992; 117: 303-308.

•Ruiz-Irastorza G, Khamashta M A. Stroke and Antiphospholipid Syndrome: The treatment debate. Rheumatology 2005. 44: 971-974.

•Ruiz-Irastorza G, Khamashta M A, Hunt B J. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5.. Arch Internal Med 2002. 162:1164-1169.

•Ruiz-Irastorza G, Hunt B J, Khamashta M A. A systematic review of secondary thrombophylaxis in patients with antiphospholipid antibodies. Arthritis and Rheumatism 2007; 57(8): 1487-1495.

•Sharma J, Karthik S, Rao S. Catastrophic antiphospholipid antibody system. Pediatr Nephrol 2005; 20: 998-999.

•Stefano V D, Martinelli I, Manucci P M. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A Prothrombin Mutation. The New England Journal of Medicine 1999; 341(11): 801-806.

•Steinhubl S R, Tan W A, Foody J M. Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. JAMA 1999; 281 (9): 806-810.

•Tsirpanlis G, Moustakas G, Sakka E. Catastrophic Antiphospholipid syndrome in a 14-year-old child. Pediatr Nephrol 2005; 20: 519-521.

•Warkentin T E, Greinacher A. Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(3 Suppl):311S-337S.

•Wells P S, Owen C, Doucette S. Does this patient have deep vein thrombosis? JAMA 2006; 295 (2) 199-207.